Skip to main content
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.040
+0.050 (5.05%)
At close: Apr 28, 2026, 4:00 PM EDT
1.060
+0.020 (1.92%)
After-hours: Apr 28, 2026, 5:02 PM EDT

Celularity Revenue

Celularity had revenue of $5.28M in the quarter ending September 30, 2025, a decrease of -43.16%. This brings the company's revenue in the last twelve months to $40.58M, down -15.81% year-over-year. In the year 2024, Celularity had annual revenue of $54.22M with 138.11% growth.

Revenue (ttm)
$40.58M
Revenue Growth
-15.81%
P/S Ratio
0.74
Revenue / Employee
$329,902
Employees
123
Market Cap
29.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M-6.87M-32.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuphoria Therapeutics 14.99M
Kyntra Bio 6.44M
Dyadic International 3.09M
IGC Pharma 1.11M
Lisata Therapeutics 170.00K
Senti Biosciences Holdings 22.00K
Revenue Rankings

CELU News

More News